Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases...

Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) and Tata Consultancy Services (TCS) have marked 25 years of collaboration on wireless network test platforms deployed around the globe, beginning with...

-- Findings from two health economics analyses of Acthar Gel provide further insight into its cost-effectiveness as a treatment option for advanced symptomatic sarcoidosis,1 and its impact on...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today...

NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto,...